Clin Exp Emerg Med.  2017 Sep;4(3):121-127. 10.15441/ceem.17.226.

Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury

Affiliations
  • 1Department of Emergency Medicine, Bradford Royal Infirmary, Bradford, UK. Alastair.Jones@bthft.nhs.uk
  • 2Global Medical Affairs, Abbott Point of Care, Princeton, NJ, USA.

Abstract

Head injury is a common presenting complaint amongst emergency department patients. To date, there has been no widespread utilization of neuro-biomarkers to aid the diagnosis of traumatic brain injury. This review article explores which neuro-biomarkers could be used in the emergency department in aiding the clinical diagnosis of mild traumatic brain injury. Based on the available evidence, the most promising neuro-biomarkers appear to be Glial fibrillary acidic protein (GFAP) and Ubiquitin C-Terminal Hydrolase Isozyme L1 (UCH-L1) as these show significant rises in peripheral blood levels shortly after injury and these have been demonstrated to correlate with long-term clinical outcomes. Treatment strategies for minor traumatic brain injury in the emergency department setting are not well developed. The introduction of blood neuro-biomarkers could reduce unnecessary radiation exposure and provide an opportunity to improve the care of this patient group.

Keyword

Brain concussion; Biomarkers; Craniocerebral trauma
Full Text Links
  • CEEM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr